Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2010
11/03/2010EP2245014A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/03/2010EP2244789A2 Combination of metformin and an mtp inhibitor
11/03/2010EP2244725A1 Novel peptides and protein and uses thereof
11/03/2010EP2244707A1 Tetrahydrocyclopentaýc¨acridine derivatives as kinase inhibitors and biological applications thereof
11/03/2010EP2244706A1 Glucokinase activators
11/03/2010EP2244705A1 Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl]benzoic acid
11/03/2010EP2049544B1 Purinone derivatives as hm74a agonists
11/03/2010EP1973541B1 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
11/03/2010EP1951725B1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases
11/03/2010EP1882474B1 Prophylactic/therapeutic agent for abnormalities of lipid metabolism
11/03/2010EP1745002B1 Novel compounds, their preparation and use
11/03/2010EP1499742B1 Nad(p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1490080B1 medical use of anthocyanins extracted from black rice
11/03/2010EP1469834B1 Multi-stage oral drug controlled-release system
11/03/2010EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010EP1159457B1 T cell receptor vbeta - dbeta - jbeta) sequence and methods for its detection
11/03/2010CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide
11/03/2010CN1872137B Drop pills of total glycoside of Jiaogulan, and preparation method
11/03/2010CN1812812B Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis
11/03/2010CN1615295B Compounds for treatment of inflammation, diabetes and related disorders
11/03/2010CN101878209A Oxypiperidine derivatives and methods of use thereof
11/03/2010CN101878199A 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
11/03/2010CN101878036A A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
11/03/2010CN101875918A Recombinant adenovirus of human hephaestin gene, preparation method thereof and application thereof
11/03/2010CN101875896A Ganoderma wine of green industry
11/03/2010CN101875700A Method for improving bioactivity of exendin fusion protein
11/03/2010CN101875684A Compound with functions of blocking cholesterol esterification and lowering cholesterol
11/03/2010CN101875636A Imidazoline-2,4-diketone derivative and preparation method and applications thereof
11/03/2010CN101875617A Carbamyl aromatic acid compound with alkoxy replacing aromatic ring, preparation method and application thereof
11/03/2010CN101874897A Immunomodifier for reducing blood total cholesterol and administration method thereof
11/03/2010CN101874875A Chinese medicinal tea for treating hypertension, hyperlipoidemia and high blood viscosity and preparation method thereof
11/03/2010CN101874862A Traditional Chinese medicine for treating hyperlipidemia
11/03/2010CN101874848A Digitalis extract, preparation method and application thereof
11/03/2010CN101874834A New application of processed products of Chinese goldthread stir-fried with rice vinegar
11/03/2010CN101874833A Novel application of wine-roasted Chinese goldthread processed product
11/03/2010CN101874832A Wine-steamed Chinese goldthread processed product as well as preparation method and application thereof
11/03/2010CN101874831A New application of coptis product processed by ginger juice
11/03/2010CN101874830A New application of golden thread processed product
11/03/2010CN101874824A Active extract containing trilobatin and application thereof
11/03/2010CN101874818A Medicament or health-care product composition for reducing blood pressure or blood fat and preparation method and application thereof
11/03/2010CN101874815A Compound nutritional tricholoma matsutake capsule
11/03/2010CN101874810A Tibetan Mastiff gall powder capsule and preparation method thereof
11/03/2010CN101874802A Slow-release medicinal composition for treating hypertension and high cholesterol
11/03/2010CN101874801A Application of pyridine compounds in preparing medicaments for treating diabetic nephropathy
11/03/2010CN101874787A Riboflavin sodium phosphate freeze-dried powder injection and preparation method thereof
11/03/2010CN101347168B Freezing beverage containing ginger sugar juice and method of preparing the same
11/03/2010CN101342159B Application of bromine phenolic compound in preparing medicament for treating type 2 diabetes or adiposis
11/03/2010CN101297806B Novel use of adenylate activated protein kinase inhibitor Compound C
11/03/2010CN101279076B Medicinal liquor for cleaning vascular lipids and preventing cerebrovascular disease
11/03/2010CN101229269B Blood-sugar reducing Chinese traditional medicine preparation capsule for treating diabetes
11/03/2010CN101103966B Omega-3 falty acid-garlic oil capsule and manufacturing method thereof
11/03/2010CN101095947B Multilevel bionic melissa powder and the method for preparing the same
11/03/2010CN101052657B Method for production of indigestible dextrin comprising isoglucose
11/03/2010CN101007116B A traditional Chinese medicine for treating diabetes mellitus and complications as a supplementation therapy
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825113 2-oxy-benzoxazinone derivatives for the treatment of obesity
11/02/2010US7824695 recombinant proteins comprise cell recognition moiety that binds alpha 2 macroglobulin receptor, and bioactive moiety (pseudomonas exotoxin), which mediates systemic effect, does not function as immunogen and does not have ADP ribosylating activity
11/02/2010CA2686545C Deuterated morpholinyl compounds
11/02/2010CA2611181C Agent for inhibiting visceral fat accumulation
11/02/2010CA2460121C 3-substituted-4-pyrimidone derivatives
11/02/2010CA2448244C Use of the acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus
11/02/2010CA2437481C The use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123930A2 Chemosensory receptor ligand-based therapies
10/28/2010WO2010123845A2 Siderophore conjugate immunogenic compositions and vaccines
10/28/2010WO2010123838A2 Novel amide and amidine derivatives and uses thereof
10/28/2010WO2010123150A1 2-aryl imidazoline derivatives
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123047A1 Crystal of benzoxazinone compound
10/28/2010WO2010123018A1 Diazaspiroalkane derivative
10/28/2010WO2010123017A1 Tetrazole compound
10/28/2010WO2010123016A1 Carboxylic acid compound
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010122151A1 3 -azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010WO2010122090A1 Fgfr1c antibody combinations
10/28/2010WO2010121559A1 Novel exendin variant and conjugate thereof
10/28/2010WO2010093849A3 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
10/28/2010WO2010091981A3 Products comprising n-phenylpropenoyl amino acid amides and uses thereof
10/28/2010WO2010077976A3 Prokineticin receptor antagonists and uses thereof
10/28/2010US20100273886 Formulations and methods for lyophilization and lyophilates provided thereby
10/28/2010US20100273884 Method for stable and controlled delivery of (-)-hydroxycitric acid
10/28/2010US20100273880 Storage-stable aqueous composition comprising a magnesium compound and l-carnitine
10/28/2010US20100273873 Direct compressible dextrose
10/28/2010US20100273872 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273853 Novel isoindol derivatives as ep4 receptor agonists
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273842 Amine derivatives having npy y5 receptor antagonistic activity and the uses thereof
10/28/2010US20100273841 Amine-derivatives having npy y5 receptor antagonistic activity and the uses thereof
10/28/2010US20100273839 Compounds Having Activity in Correcting Mutant-CFTR Processing and Uses Thereof
10/28/2010US20100273829 Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273816 Quinazoline Compounds
10/28/2010US20100273809 Method and composition for treating an alpha adrenoceptor-mediated condition
10/28/2010US20100273806 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 1298